4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-22-018298
Options or other derivatives
- Chief R&D Officer acquired 475,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cavanagh William Chief R&D Officer | 2022-07-21 | Grant or award · Stock Options (right to buy) | +475,000 | 1,493,846 | D: show line 1 in the form |
Loading xslF345X03/rdgdoc.xml…